1. Home
  2. LKFN vs ARDX Comparison

LKFN vs ARDX Comparison

Compare LKFN & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Financial Corporation

LKFN

Lakeland Financial Corporation

HOLD

Current Price

$60.00

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.56

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKFN
ARDX
Founded
1872
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
LKFN
ARDX
Price
$60.00
$5.56
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$67.00
$15.14
AVG Volume (30 Days)
159.5K
3.0M
Earning Date
04-27-2026
04-30-2026
Dividend Yield
3.49%
N/A
EPS Growth
10.47
N/A
EPS
1.04
N/A
Revenue
$985,000.00
$2,607,000.00
Revenue This Year
$15.50
$37.75
Revenue Next Year
$5.51
$34.24
P/E Ratio
$57.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.36
$3.54
52 Week High
$69.38
$8.40

Technical Indicators

Market Signals
Indicator
LKFN
ARDX
Relative Strength Index (RSI) 53.19 36.36
Support Level $58.03 $5.49
Resistance Level $60.94 $6.23
Average True Range (ATR) 1.35 0.26
MACD 0.01 -0.10
Stochastic Oscillator 81.49 20.35

Price Performance

Historical Comparison
LKFN
ARDX

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare. The company's revenue is derived from the business of banking.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: